Navigation Links
AgriLife research hibiscus breeder comes up with the blue
Date:9/3/2010

ok four years of work and more than 1,000 crosses among three winter-hardy hibiscus species to achieve this goal of creating an almost-blue flowering hibiscus hybrid," he said. The new hybrid is not perfect yet, Malinowski said.

"The flowers get a fantastic blue hue in shade, but in full sunlight they are still plum-lavender-bluish," he said.

Brown said it is important to note that in the world of ornamentals, "blue" is interpreted to have a wide range of hues. Most ornamental blues have a more purple or lavender cast.

"There are very few true blue flowers in any ornamental cultivar," he said. "Although I would call this flower 'almost blue' as Dariusz has, there is no question that this development is unique in known hardy hibiscus color ranges.

"My expectation is that we will see more vibrant colors in next year's F1s (cultivars) using this line as a parent," Brown said.

Malinowski said he will use this plant as a parent in his breeding project this summer, with the goal to stabilize the blue color in full sunlight and increase flower size from the current 7 inches to the "magic" 12-inch diameter.

Breeding of ornamental plants is not the major research area of Malinowski, but he said he enjoys new challenges and the benefits of combining his private hobby with business.

"I never thought I would be an expert in breeding winter-hardy hibiscus," he said. "The knowledge I have gained during the past few years of intensive work on hardy hibiscus helps me reach most of the breeding objectives in a relatively short time."

What is next? Malinowski and his collaborators have a new challenge - to create an orange flowering hardy hibiscus.

This goal seems to be even more difficult, but not impossible, Malinowski said. It will require hybridization with a distantly related hibiscus species, which has shades of orange flowers. The researchers hope that with
'/>"/>

Contact: Dr. Dariusz Malinowski
dmalinow@ag.tamu.edu
940-552-9941
Texas A&M AgriLife Communications
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. AgriLife scientists do groundwork for genetic mapping of algae biofuel species
2. Texas AgriLife researchers helping
3. Unique winter-hardy hibiscus has roots with AgriLife Research scientist in Vernon
4. Research about Brazilian marine biodiversity brings researchers from 5 countries together
5. Researchers identify how bone-marrow stem cells hold their breath in low-oxygen environments
6. SRNL, Chernobyl Laboratory collaborate on research initiatives
7. Lupus Research Institute-funded study points to increased risk for lupus in men
8. Bochums researchers discover proton diode
9. U-M researchers receive largest single collection of psoriasis DNA samples
10. Why does anxiety target women more? FSU researcher awarded $1.8 million grant to find out
11. Researchers analyze the environmentalists paradox
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AgriLife research hibiscus breeder comes up with the blue
(Date:5/11/2015)... 11, 2015 Curemark LLC, a privately held ... a new Phase III double blind, randomized, placebo-controlled clinical ... CM-AT, on all children ages 3-8 with Autism. Previously, ... III double blinded clinical trial for CM-AT in children ... the digestive enzyme chymotrypsin. This new trial will help ...
(Date:5/8/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leading ... the executive management team will present at the following investor ... Telecom Conference Date: May 18, 2015 Time: 10:40am ... Cowen and Company Technology, Media & ... The New York Palace Hotel, New York, NY ...
(Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... of the 1962 Nobel Prize with Francis Crick and Maurice ... DNA, will present "Curing Incurable Cancer" and attend other events ... the James Graham Brown Cancer Center at the University of ... 5, at the Brown Theater, 315 W. Broadway, Louisville. Admission ...
... early stages of a major cause of failure in joint ... avoid additional surgery. More than 1.5 million total joint replacement ... is 90 per cent, almost 10 per cent of implants ... journal Molecular Pharmaceutics . Dong Wang and colleagues ...
... do not rely on oxygen may have played an important ... to a theory that UChicago researcher Albert Colman is testing ... Siberia. He has found that bacteria at the site ... that scientists must take into account as they attempt to ...
Cached Biology News:UofL hosts address by Nobel Laureate, DNA structure co-discoverer James Watson 2Cold case: Siberian hot springs reveal ancient ecology 2Cold case: Siberian hot springs reveal ancient ecology 3
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... 21, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company focused on the development of autologous ... at the International Society for Cellular Therapy (ISCT) ... tendinosis currently in a Phase 1/2 clinical trial.  ... from 5:30 PM to 7:00 PM local ...
(Date:5/20/2015)... , May 20, 2015 ... presented preliminary data demonstrating the ability of the ... fibrosis (IPF) from other interstitial lung diseases (ILDs) ... the classifier,s potential to help thousands of patients ... ambiguity in IPF diagnosis – a frequent challenge ...
(Date:5/20/2015)... , May 19, 2015 Research and Markets ... of the "Global Cell Therapy Market Outlook 2020 ... of cell therapy in tissue and regenerative medicine is ... no other options which could help in the growth ... this segment but they are unable to form new ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
Rabbit polyclonal to hnRNP-U...
... DNase I (RNase-free) (E.C. 3.1.21.1) is ... DNA and chromatin. It functions by hydrolyzing ... a 5'-phosphate and a 3'-hydroxyl group. Ambion's ... purity available and is recommended to degrade ...
... Agarose Gel-Digesting Preparation contains a unique β-agarose ... quantitative recovery of intact DNA and RNA ... following electrophoresis in TAE, TBE, MOPS, or ... directly in the TAE, TBE, MOPS, and ...
... sheer in-house demand is causing shortages in your ... This can cause unwanted distractions, problems and delays. ... your hard work and endeavour! Bring us your ... market it internationally. We work under ISO 9001 ...
Biology Products: